SCHEMBL8566577

SCHEMBL8566577

Clc1nc(Cl)c(Sc2ccccc2)c(Cl)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.42
DRD2 P14416 3/20 0.42
DRD4 P21917 3/20 0.42
KDM1A O60341 1/20 0.39
HPGD P15428 4/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
MAPT P10636 2/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
MGLL Q99685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8566460 0.83 HTR1A (0.45) HTR1ADRD2DRD4HPGDALDH1A1
SCHEMBL8571069 0.80 KDM4E (0.45) HPGDALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL8564591 0.79 HTR1A (0.64) HTR1ADRD2DRD4HPGDALDH1A1
SCHEMBL8566180 0.79 HTR1A (0.41) HTR1ADRD2DRD4KDM1AHPGD
SCHEMBL8570726 0.78 PDE4A (0.42) HTR1ADRD2DRD4KDM1AHPGD
SCHEMBL6847060 0.76 CXCL12 (0.47) KDM1AHPGDALDH1A1SMN1; SMN2MEN1
SCHEMBL17795952 0.76 CXCL12 (0.52) KDM1AHPGDALDH1A1SMN1; SMN2MEN1
SCHEMBL17302068 0.74 L3MBTL1 (0.41) HTR1ADRD2DRD4KDM1AALDH1A1
SCHEMBL1741595 0.74 LMNA (0.41) HTR1ADRD2DRD4KDM1AALDH1A1
SCHEMBL8723876 0.72 HPGD (0.53) KDM1AHPGDALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0826674-A1 NOVEL PYRIMIDINE DERIVATIVES EFFICACIOUS AS PSYCHOTROPIC DRUG AND PROCESS FOR THE PRODUCTION THEREOF SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1998-03-04 EP disclosed